Bank Nifty appears more exhausted, prompting to be cautious, says Geojit Financial Services

By Anand James

Though Monday’s opening gains could not be sustained, and upsides kept getting capped through the rest of the week, there was a marked departure from the previous week’s sell-on-rallies mode with the market witnessing a buy-on-dips approach. As a result, though benchmark indices may not have much to show on the board, a broad market recovery appears to be in play. Meanwhile, 83% of NSE 500 stocks closed above their respective 10-day SMA on Friday, when compared to just 35% on the previous Friday, and more than 63% of the constituent stocks bounced at least 1% from Friday’s lows, confirming strength across the board.

Nifty appears rejuvenated after last week’s consolidation

Last week, while turning bullish and setting a target of 25262, we were clear of the prospects of a turn lower prior to that. The recovery post expiry, from the 23900 vicinity is suggestive of regrouping of bulls. We are encouraged to eye 24700, the 50-day SMA, as the near-term objective. Alternatively, the inability to float above 24230 early in the week, could see Nifty drifting lower again, hoping for 23700 to attract bargain buying again and a regrouping of bulls. Meanwhile, Bank Nifty appears more travel weary and exhausted, prompting us to be cautious on approach to 52500. However, if we get a time correction with dips not extending past 51400, a stronger upside could unfold with upside objectives stretched to 53700.

Sectoral Cues

Pharma to gain strength

Nifty Pharma Index has been in a pullback mode since October 2024 and seems to have formed a base around 21500 and a reversal is underway on the weekly scale. The Stochastic Momentum histogram has shown signs of exhaustion at lower levels on the weekly scale and the stock has bounced off the Supertrend level of 21500 hinting at the continuation of the ongoing reversal. Expect the current reversal to push the index towards 22750-22950 in the near term. Aurobindo Pharma, Sun Pharma, Cipla, Zyduslife, Divi’s Lab, Torrent Pharma and Alkem Lab are expected to lead the index.

Reversal seen in Oil & Gas

The Nifty Oil & Gas index has been on a decline since August 2024 and has seen a Morning Star candlestick pattern in the weekly time frame indicating the start of a reversal. The Stochastic Momentum histogram has shown signs of exhaustion at lower levels on the weekly scale and stock is close to breaking above the Supertrend level in the daily time frame.

 » Read More

Related Articles

Godrej Properties sells over 300 homes worth Rs 1,000 crore at newly launched Hyderabad project

Godrej Properties on Tuesday announced that it has sold homes worth over Rs 1,000 crore with a total area of approximately 0.84 million sqft in its project, Godrej Madison Avenue, located in Kokapet, Hyderabad. The project was launched in January 2025 and represents Godrej Properties’ entry into Hyderabad, further strengthening its presence in Southern India. 

Motilal Oswal initiates coverage on Suzlon Energy with Buy; expects 21% jump in 12 months

Suzlon Energy has rallied 6 per cent in last 1 month but the share price is down 11% in 2025 so far. In case, you are wondering what’s the best strategy for the stock, Motilal Oswal has initiated coverage with a Buy rating and a target price of Rs 70 per share. That implies an

Dalmia Bharat surges 2%: 4 reasons UBS upgrade to Buy from Sell sparks rally

The shares of Dalmia Bharat is rallying on the back of a big upgrade from UBS. The international brokerage firm has changed its recommendation to ‘Buy’ from ‘Sell’. The share price of Dalmia Bharat has delivered 3% return over the past 5 trading sessions. What is driving this upgrade? Let’s take a look at the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Godrej Properties sells over 300 homes worth Rs 1,000 crore at newly launched Hyderabad project

Godrej Properties on Tuesday announced that it has sold homes worth over Rs 1,000 crore with a total area of approximately 0.84 million sqft in its project, Godrej Madison Avenue, located in Kokapet, Hyderabad. The project was launched in January 2025 and represents Godrej Properties’ entry into Hyderabad, further strengthening its presence in Southern India. 

Motilal Oswal initiates coverage on Suzlon Energy with Buy; expects 21% jump in 12 months

Suzlon Energy has rallied 6 per cent in last 1 month but the share price is down 11% in 2025 so far. In case, you are wondering what’s the best strategy for the stock, Motilal Oswal has initiated coverage with a Buy rating and a target price of Rs 70 per share. That implies an

Dalmia Bharat surges 2%: 4 reasons UBS upgrade to Buy from Sell sparks rally

The shares of Dalmia Bharat is rallying on the back of a big upgrade from UBS. The international brokerage firm has changed its recommendation to ‘Buy’ from ‘Sell’. The share price of Dalmia Bharat has delivered 3% return over the past 5 trading sessions. What is driving this upgrade? Let’s take a look at the

Britannia Industries Share Price Today Live Updates, 25 Mar, 2025: Britannia Industries on the radar

Go to Live UpdatesBritannia Industries Share Price Today Live Updates, 25 Mar, 2025: The Britannia Industries share is in news and the counter closed trade on 24 Mar, 2025 at Rs 4808.65. The shares touched intraday high of Rs 4830.0 in the last trading session while the intraday low was at Rs 4767.5. The company’s

‘We remain watchful for risk across our portfolios’, says Anup Saha

Bajaj Finance aims to have a share of 4-5% in retail credit over the next five years as it builds new lines of business, MD-designate Anup Saha tells Shobhana Subramanian. Excerpts: In this digital age, how many customers do you expect to be servicing in the next five years? How big is the cross-selling opportunity?